AbbVie (ABBV)
(Delayed Data from NYSE)
$166.41 USD
+1.75 (1.06%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $166.41 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO4/26/24 |
---|---|
Current Quarter | 2.26 |
EPS Last Quarter | 2.79 |
Last EPS Surprise | 1.09% |
ABR | 1.89 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 11.12 |
Next Year | 12.17 |
EPS (TTM) | 11.11 |
P/E (F1) | 14.97 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.99B | 13.51B | 54.63B | 58.40B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 12.53B | 13.72B | 55.76B | 59.76B |
Low Estimate | 11.88B | 12.99B | 54.24B | 56.93B |
Year ago Sales | 12.23B | 13.87B | 54.32B | 54.63B |
Year over Year Growth Est. | -1.90% | -2.54% | 0.58% | 6.89% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.26 | 2.79 | 11.12 | 12.17 |
# of Estimates | 5 | 9 | 6 | 10 |
Most Recent Consensus | 2.22 | 2.84 | 11.02 | 11.71 |
High Estimate | 2.41 | 2.92 | 11.35 | 12.62 |
Low Estimate | 2.20 | 2.62 | 11.02 | 11.71 |
Year ago EPS | 2.46 | 2.91 | 11.11 | 11.12 |
Year over Year Growth Est. | -8.13% | -4.12% | 0.09% | 9.42% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 2 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 2 | 4 | 2 |
Down Last 60 Days | 4 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.26 | 2.79 | 11.12 | 12.17 |
7 Days Ago | 2.26 | 2.79 | 11.12 | 12.17 |
30 Days Ago | 2.33 | 2.79 | 11.13 | 12.20 |
60 Days Ago | 2.34 | 2.79 | 11.13 | 12.15 |
90 Days Ago | 2.44 | 2.84 | 11.19 | 12.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.26 | 2.80 | 11.13 | 12.39 |
Zacks Consensus Estimate | 2.26 | 2.79 | 11.12 | 12.17 |
Earnings ESP | 0.00% | 0.22% | 0.13% | 1.80% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.79 | 2.95 | 2.91 | 2.46 | NA |
Estimate | 2.76 | 2.86 | 2.79 | 2.44 | NA |
Difference | 0.03 | 0.09 | 0.12 | 0.02 | 0.07 |
Surprise | 1.09% | 3.15% | 4.30% | 0.82% | 2.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more